Experts studying the new variant, C.1.2, are surprised by its substantial mutations but are confident current vaccines will be effective against it
Experts studying the new variant are surprised by its substantial and unexpected mutations but are confident that current vaccines will be effective against it
This content is restricted to subscribers only.
Join the M&G Community
Our commitment at the Mail & Guardian is to ensure every reader enjoys the finest experience. Join the M&G community and support us in delivering in-depth news to you consistently.
Subscribe
Subscription enables:
- – M&G community membership
- – independent journalism
- – access to all premium articles & features
- – a digital version of the weekly newspaper
- – invites to subscriber-only events
- – the opportunity to test new online features first
Already a subscriber?
Login here.